Moonbase
← Back to Awards
R01NIH · NATIONAL CANCER INSTITUTENIH

IDP mediated transcriptional stabilization as a cause of AML

Bernt, Kathrin M (Contact)·CHILDREN'S HOSP OF PHILADELPHIA, PA·2022–2027·ACTIVE
Donate

INSTITUTION

CHILDREN'S HOSP OF PHILADELPHIA, PA

PRINCIPAL INVESTIGATOR

Bernt, Kathrin M (Contact)

FUNDING

$236K

YEAR

2022

MOONBASE SCORE

Still being scored

LOADING MOONBASE SCORE

Abstract

PROJECT SUMMARY High expression of the intrinsically disordered protein Meningioma-1 (MN1) is common in AML, and associated with a poor prognosis. Forced expression of MN1 in murine hematopoietic progenitors induces an aggressive leukemia. We recently discovered that the primary interaction partner of MN1 is the BAF nucleosome-positioning complex. MN1 stabilizes BAF on chromatin. MN1 binding is associated with sustained active enhancer chromatin at enhancers regulating a hematopoietic stem/progenitor program. Intriguingly, MN1’s entire coding frame is disordered. We hypothesize that MN1 causes AML by overstabilizing transcriptional hubs by increasing multi- valent, low affinity interactions that result in high local concentrations of BAF and early hematopoietic transcription factors. A better understanding of how MN1 causes leukemia may identify opportunities for targeted therapies in a patient population who is failing conventional AML therapy.

R01NATIONAL CANCER INSTITUTECancer Molecular Pathobiology Study Section[CAMP]resultregulatingpopulationinteractionsidentifymulticoncentrationstherapiestranscriptionallocaltherapytranscriptionbettermeningiomaactivebindingprogenitors

Are you the primary organization running this research?

The two tools below are built for the principal investigator & host institution behind this project.